Physician profile
Minda A Green
NPI 1245493022
$10,191.75
in general payments reported to CMS, 2019-2025
20 companies · $3,018 in 2025
The $3,018 reported for 2025 was more than what 92% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,077 · 2020: $2,731 · 2021: $397 · 2022: $322 · 2023: $287 · 2024: $360 · 2025: $3,018.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,663 · Food and Beverage: $825 · Education: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,662.58 |
| Food and Beverage | $825.25 |
| Education | $177.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fujifilm New Development USA, INC. | $5,425.21 | 2019-2020 | |
| Gynesonics, INC. | $3,360.76 | 2019-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Intuitive Surgical, INC. | $295.86 | 2022-2023 | Da Vinci Surgical System |
| Axonics, INC. | $225.73 | 2023-2024 | Bulkamid, Axonics |
| Abbvie INC. | $218.22 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $145.85 | 2025 | |
| Channel Medsystems, INC. | $116.80 | 2025 | |
| Coloplast Corp | $76.43 | 2022 | |
| Sumitomo Pharma America, INC. | $50.70 | 2024-2025 | Myfembree |
| Ethicon US, LLC | $46.75 | 2020 | |
| Astellas Pharma US INC | $37.94 | 2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $37.53 | 2020 | |
| Medtronic, INC. | $29.95 | 2023 | Truclear |
| Myovant Sciences INC. | $25.75 | 2022 | |
| Organogenesis INC. | $21.69 | 2025 | Cygnus Dual |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $20.75 | 2023 | Arista Ah Flexitip |
| Pfizer INC. | $17.38 | 2024 | |
| Agile Therapeutics, INC. | $15.65 | 2021 | |
| Hologic Sales and Service, LLC | $11.46 | 2021 | |
| Merck Sharp & Dohme LLC | $11.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Minda Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.